[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

A New Drug for Relapsed/Refractory Myeloma Patients: Melflufen

A New Drug for Relapsed/Refractory Myeloma Patients: Melflufen image

A New Drug for Relapsed/Refractory Myeloma Patients: Melflufen

Webinar
event Apr 02, 2021 / 07:00PM - 08:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

A new treatment for multiple myeloma called melflufen (PEPAXTO®) was recently FDA-approved for relapsed or refractory multiple myeloma patients who have received at least four prior lines of therapy. Join us to hear Dr. Agne Paner of Rush University explain what the new therapy is, who qualifies for it, when it should be considered and how it works. Come with questions for the Q&A!

Schedule & Agenda

Event panelist Jenny Ahlstrom
07:00 PM
Introductions
Jenny Ahlstrom
Jenny introduces the new Myeloma Community Chapter, the event agenda, and our featured speaker, Dr. Agne Paner. 
Event panelist Dr. Agne Paner
07:05 PM
Presentation
Dr. Agne Paner
Dr. Paner explains what the melflufen is, who qualifies for it, and how it works. Come with questions! 
Event panelist Audience
07:40 PM
Questions and Answers
Audience
Ask your questions about this new treatment to Dr. Paner! 

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio
The panelist Agne Paner, MD
Agne Paner, MD

Dr. Paner is an Associate Professor of Medicine in the Multiple Myeloma and Amyloidosis Program at Rush Medical College. Her research interests include clinical trials with innovative approaches to the treatment of patients with multiple myeloma and amyloidosis. She had hands-on experience in the HORIZON trial. She has been treating multiple myeloma for over 10 years and takes care of about 200 patients with multiple myeloma a year.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Disease Progression and Relapsed/Refractory group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.